Allied Market Research


Diabetic Eye Disease Devices Market

Diabetic Eye Disease Devices Market Size, Share, Competitive Landscape and Trend Analysis Report by Devices, by Diseases and by End-User : Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Medical Devices & Supplies

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

Diabetic eye disease devices are medical devices used to treat and diagnose renal complications that occur due to diabetes. The most common diabetic eye diseases include diabetic retinopathy, diabetic macular edema, cataract, and glaucoma. These conditions may lead to complete blindness if not treated on time.

The growing prevalence of diabetic eye diseases owning to increasing smoking addiction, eye injury, hormone replacement therapy, and diseases such as diabetes, hypertension, and obesity drive the diabetic eye disease devices market growth. In addition, increasing geriatric population who suffer from diabetic eye diseases increases the market growth.

There is an increasing demand for diabetic eye diseases devices to avoid visual impairment and loss of vision. However, dearth of skilled professionals with expertise in ophthalmic surgery, lack of healthcare infrastructure in developing countries, low awareness of eye surgery, and stringent government regulations associated with the safety & efficacy of medical devices hamper the market growth. Ongoing R&D activities related to diabetic eye disease devices are anticipated to present new opportunities for the market.

The market is segmented on the basis of devices, diseases, end-users, and region. Based on devices, the market is divided into surgery, ophthalmic diagnostic & monitoring equipment, and vision care. Based on diseases the market is categorized into diabetic retinopathy, diabetic macular edema (DME), cataract, glaucoma, and others. Based on end-users the market is segmented into hospitals, ophthalmic clinics, and others. Based on region, the global diabetic eye disease devices market is segmented into North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits:

  • The study provides an in-depth analysis of the global diabetic eye disease devices market, with current trends and future estimations to elucidate investment pockets.
  • Comprehensive analysis of factors that drive and restrict the growth of the market has been provided.
  • The report provides a quantitative analysis to help stakeholders capitalize on prevailing market opportunities in terms of value.
  • Extensive analysis of different segments helps understand various products of the market.
  • Key players have been profiled and their strategies thoroughly analyzed, which predict the competitive outlook of the market.

Diabetic Eye Disease Devices Market Report Highlights

Aspects Details
By Devices
  • Surgery
    • Cataract Surgery Devices
      • Intra Ocular Lens (IOL)
        • Monofocal
        • Multifocal
        • Toric
        • Accomodating
      • Ophthalmic Viscoelastic Devices
        • Cohesive
        • Dispersive
      • Phacoemulsification Devices
    • Glaucoma Surgery Devices
      • Glaucoma Drainage Devices
      • Glaucoma Lasers
      • Stents and Implants
      • Systems
    • Refractive Surgery Devices
    • Microkeratome
    • Vitreo Retinal Surgery Devices
      • Vitrectomy Machines
      • Photocoagulation Lasers
    • Ophthalmic Lasers
      • Excimer Laser
      • Femtosecond Laser
      • YAG Laser
      • Glaucoma Lasers
      • Photocoagulation Lasers
  • Ophthalmic Diagnostic & Monitoring Equipment
    • Optical Coherence Tomographers (OCT Scanners)
    • Fundus Cameras
      • Non-Mydriatic
      • Mydriatic
      • Others
    • Slit Lamps
    • Visual Field Analyzers/Perimeters
    • Wavefront Aberrometers
    • Ophthalmic Ultrasound Imaging Systems
    • Ophthalmoscopes
    • Tonometers
    • Autorefractors/Phoropters
    • Keratometers
    • Corneal Topographers
    • Retinoscope
    • Pachymeter
    • Specular Microscope
    • Biometers
    • Optotype Projectors
    • Dioptometers
  • Vision Care
    • Contact Lens
    • Spectacles
By Diseases
  • Diabetic Retinopathy
  • Diabetic Macular Edema (DME)
  • Cataract
  • Glaucoma
  • Others
By End-User
  • Hospitals
  • Ophthalmic Clinics
  • OthersOthersOthersOthersOthers
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players

Valeant Pharmaceuticals International, Inc., STAAR Surgical Company, Actavis plc, Novartis AG, Aaren Scientific Inc., Johnson & Johnson, Alcon Inc., CooperVision AG, Essilor International S.A., Nidek Co., Ltd.

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Diabetic Eye Disease Devices Market

Global Opportunity Analysis and Industry Forecast, 2023-2032